The AstraZeneca-Oxford Coronavirus (COVID-19) vaccine protects against a more transmissible variant of the virus first identified in the United Kingdom, according to research published Friday.

The study, which has not yet been peer-reviewed, found that the vaccine is 74.6 percent effective against the variant, “similar” but somewhat lower than the 84 percent effectiveness against the non-variant strain.

The effectiveness of a range of vaccines against the U.K. variant, also known as B.1.1.7, has been reassuring, though experts are more concerned about at least some drop in effectiveness rates against a different variant first found in South Africa.

The Oxford researchers said they are working with AstraZeneca to prepare to update the vaccine to fight new variants if necessary, as are other companies working on vaccines.

This article was originally by the Hill on Feb. 5, 2021
http://bit.ly/3aTucaL

FIND the model and photographer created this video on Pexels:
https://bit.ly/3aqnKYj

SUBSCRIBE to our channel:
http://bit.ly/3pOwYUZ